These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5157761)

  • 1. Physicochemical characterization of the fifth (C5), sixth (C6), seventh (C7), eighth (C8) and ninth (C9) component of guinea pig complement.
    König W; Bitter-Suermann D; Dierich M; Hadding U
    Eur J Immunol; 1971 Nov; 1(5):372-6. PubMed ID: 5157761
    [No Abstract]   [Full Text] [Related]  

  • 2. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of isoelectric points of guinea pig complement components.
    Mukojima T
    Bull Tokyo Med Dent Univ; 1970 Jun; 17(2):75-88. PubMed ID: 5271548
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrophoresis of guinea-pig complement components (C3, C5, C6, C7, C8 and C9) on polyacrylamide gel.
    Okada H; Mayumi M; Mukojima T; Sekine T; Torisu M
    Immunology; 1970 Apr; 18(4):493-500. PubMed ID: 5421032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
    Yamamoto KI
    J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
    Balkarowa-Ständer J; Rother U; Rauterberg EW
    J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution.
    Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
    J Exp Med; 1973 Aug; 138(2):428-37. PubMed ID: 4737061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.
    Hänsch G; Rother U; Rother K
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):48-59. PubMed ID: 868206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fifth component of complement (C5): purification without activation.
    Dessauer A; Rother U
    Immunobiology; 1983 May; 164(5):370-9. PubMed ID: 6347874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
    Nemerow GR; Yamamoto KI; Lint TF
    J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification and characterization of the ninth component of rabbit complement.
    Hänsch GM; Rummel G; Gänzler F
    Complement; 1984; 1(2):116-22. PubMed ID: 6544183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of different serological activities associated with immunoglobulins from sera of rabbits immunized with rat erythrocytes.
    Kastelan M; Vitale L; Vitale B
    Eur J Immunol; 1971 Nov; 1(5):363-6. PubMed ID: 5003356
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement.
    Shin HS; Snyderman R; Friedman E; Mellors A; Mayer MM
    Science; 1968 Oct; 162(3851):361-3. PubMed ID: 4175690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.
    Bitter-Suermann D; Dierich M; König W; Hadding U
    Immunology; 1972 Sep; 23(3):267-81. PubMed ID: 4214761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor D in the alternate pathway of complement activation: purification, physicochemical characterization and functional role.
    Dierich MP; Hadding U; König W; Limbert M; Schorlemmer HU; Bitter-Suermann D
    Immunochemistry; 1974 Sep; 11(9):527-32. PubMed ID: 4459260
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1671-7. PubMed ID: 4750864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.